A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors

Clinical trial NCT05393063 · UNKNOWN

Trial details

NCT number: NCT05393063
Sponsor: Akeso
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-06-01
Primary completion: 2023-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.